Evidence map›Paper›PMID 2268282›Full record

ArticleThe Biochemical journal1990

Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate.

K Saini, G Steele, P Thomas

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

K SainiDepartment of Surgery, New England Deaconess Hospital, Harvard Medical School, Boston, MA 02115.
G Steele
P Thomas
Deaconess Hospital · US

Funding

THE PATHOBIOLOGY OF COLORECTAL CANCERP01CA044704 · NCI · NEW ENGLAND DEACONESS HOSPITAL · PI KOLODNER, RICHARD D · 1987 to 1998
–
METABOLISM OF CARCINOEMBRYONIC ANTIGENR01CA044583 · NCI · NEW ENGLAND DEACONESS HOSPITAL · PI THOMAS, PETER · 1986 to 1995
–
NCI NIH HHS CA 44583NCI NIH HHS CA 44704
6 · The paper itself

Abstract

The effect of sodium butyrate on the expression of the carcinoembryonic-antigen (CEA) gene was studied in two poorly differentiated colorectal-carcinoma cell lines (Clone-A and MIP-101) and in one well-differentiated cell line (LS-174T); A.T.C.C. no. CCL 188). Northern-blot and dot-blot analyses indicated a steady increase in CEA mRNA from day 4 to a maximal level by day 14 after these cells were exposed to 2 mM-sodium butyrate. Studies using nuclear run-off assays followed by dot-blot hybridization to a partial CEA cDNA clone demonstrated that specific increases in gene transcription rates (3-fold in MIP-101, 4-fold in LS-174T and 6-fold in Clone-A) are not sufficient to account for the observed increases in CEA mRNA abundance. Further studies showed that CEA-specific transcripts have a half-life of about 60-80 min, and treatment with sodium butyrate increased the stability of CEA-specific transcripts to about 340 min in LS-174T cells and to about 500 min in Clone-A cells. We conclude that the induction of the CEA-gene expression by sodium butyrate in colorectal-cancer cells is mediated by both transcriptional and post-transcriptional mechanisms, with CEA mRNA stability as one of the major check-points.

Indexed as

ButyratesButyric AcidCarcinoembryonic AntigenCell DifferentiationCell LineCell NucleusCloning, MolecularColorectal NeoplasmsDNA, NeoplasmGene Expression Regulation, NeoplasticHumansKineticsRNA, MessengerTranscription, GeneticButyratesButyric AcidCarcinoembryonic AntigenDNA, NeoplasmRNA, Messenger

Identifiers

PMID2268282
PMCPMC1149736
OpenAlexW2211316495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.